Home > Products > CD20 & CD47
> Recombinant Anti-CD20 x Anti-CD47 Bispecific Antibody (Diabody-CH3)
Recombinant Anti-CD20 x Anti-CD47 Bispecific Antibody (Diabody-CH3) (CAT#: BSDBC-052)
Recombinant Anti-CD20 x Anti-CD47 Bispecific Antibody (Diabody-CH3) is a fusion protein of two diabodies connected together by a CH3 region. In a diabody, the two scFvs with short linkers are from anti-CD20 and anti-CD47 antibodies. The VH and VL domains form an inter-chain pairing. The diabody with different specificities is fused to each of the CH3 chains, which results in 2+2 antigen-binding valency and extends the half-life of this BsAb. This BsAb can retarget macrophages to tumor cells. It is designed for the research of Lymphoma therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD20 x Anti-CD47 Bispecific Antibody (Diabody-CH3) (BSDBC-052). Click the button below to contact us or submit your feedback about this product.